A predictable consequence of the discovery that membrane-bound ACE2 is the functional receptor through which SARS-CoV-2 enters human cells was the concern that ACEi and ARBs, through the up-regulation of the expression of ACE2, may contribute to adverse outcomes related to COVID-19 (Lopes et al., 2021b). The gene discussed is ACE2; the disease is COVID-19.